PackGene aims to simplify some of the most challenging aspects of the gene therapy development and industrialization process, namely the development of rAAV serotypes, virus packaging, and GMP mass-production. PackGene seeks to provide stable, efficient, and economical rAAV Fast Services to accelerate our partners gene and cell therapy development efforts from the discovery phase through clinical trials and commercialization. With our belief in top quality service and supply, we work diligently and intelligently to develop innovative and impactful technologies that make gene and cell therapy research easier, more efficient, and more affordable. Our goal is to play an important and bright role in the field of gene therapy.
Mission Statement
Make Gene Therapy Affordable: To enhance gene therapy product development by providing an integrated one-stop shop solution to the gene therapy industry with high-quality products and services under world-class speed.
Vision Statement
Gene therapies are poised to revolutionize the world of medicine and address areas of unmet medical needs. PackGene’s proprietary π-Alpha 293 AAV High-yield Platform is positioned to alleviate industry-wide productivity bottlenecks while maintaining product safety.
PackGene strives to deliver the most efficient gene therapy manufacturing platform, making novel gene therapies accessible and more affordable to patients in need.
Core Values
- Integrity: We do what we say and say what we do.
- Innovation: Continuously improve our process to bring better therapies to the patients.
- Patient First: We always put patients first in our day-to-day operations.
- Customer dedication: We strive to exceed customers’ expectations in everyday work.
- World-class delivery speed: It’s part of our genome to always provide world-class turnaround times because patients are waiting.
